T3	Subject 14 39	a 29-year-old man with CD
T4	Effect 48 85	nodular sclerosing Hodgkin's lymphoma
T6	Treatment 100 138	3 weeks after infusion with infliximab
T7	Age 16 27	29-year-old
T8	Gender 28 31	man
T9	Treat-Disorder 37 39	CD
T10	Time_elapsed 100 107	3 weeks
T11	Route 114 122	infusion
T12	Drug 128 138	infliximab
T5	Adverse_event 90 99	diagnosed
E1	Adverse_event:T5 
